Translational molecular imaging in exocrine pancreatic cancer

Bart Cornelissen, James C Knight, Somnath Mukherjee, Laura Evangelista, Catarina Xavier, Federico Caobelli, Silvana Del Vecchio, Latifa Rbah-Vidal, Jacques Barbet, Marion de Jong, Fijs W B van Leeuwen

Research output: Contribution to journalReview article

Abstract

Effective treatment for pancreatic cancer remains challenging, particularly the treatment of pancreatic ductal adenocarcinoma (PDAC), which makes up more than 95% of all pancreatic cancers. Late diagnosis and failure of chemotherapy and radiotherapy are all too common, and many patients die soon after diagnosis. Here, we make the case for the increased use of molecular imaging in PDAC preclinical research and in patient management.

Original languageEnglish
Pages (from-to)2442-2455
Number of pages14
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume45
Issue number13
DOIs
Publication statusPublished - Dec 2018

Fingerprint Dive into the research topics of 'Translational molecular imaging in exocrine pancreatic cancer'. Together they form a unique fingerprint.

  • Cite this

    Cornelissen, B., Knight, J. C., Mukherjee, S., Evangelista, L., Xavier, C., Caobelli, F., Del Vecchio, S., Rbah-Vidal, L., Barbet, J., de Jong, M., & van Leeuwen, F. W. B. (2018). Translational molecular imaging in exocrine pancreatic cancer. European Journal of Nuclear Medicine and Molecular Imaging, 45(13), 2442-2455. https://doi.org/10.1007/s00259-018-4146-5